在犬肝细胞癌中,候选基因用于分子向治疗
Toshiyuki Tanaka1, Tomoki Motegi2, Misaki Mori1
1Laboratory of Veterinary Surgery, School of Veterinary Science, Osaka Metropolitan University, Osaka, Japan.
BMC research notes
|December 2, 2024
概括
向治疗犬肝癌 (HCC) 疗效尚不清楚,因为基因表达数据有限. 这项研究确定了犬类HCC中关键的上调和下调基因,有助于未来的治疗开发.
科学领域:
- 兽医瘤学 兽医瘤学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 无法切除的犬肝细胞癌 (HCC) 具有有限的非手术治疗途径.
- 索拉费尼布是一种针对犬类HCC的向疗法,但由于对基因表达的数据不足,其疗效尚不确定.
研究的目的:
- 为了研究犬类HCC.的基因表达特征.
- 与正常肝脏组织相比,在狗HCC中识别差异表达基因 (DEGs).
- 通过了解基因表达模式来评估向疗法的潜力.
主要方法:
- 进行了RNA测序 (RNA-seq) 在患有HCC和没有HCC的狗的肝脏样本上.
- 从样本中提取信使RNA (mRNA) 来进行分析.
- 通过将犬类HCC与正常肝脏进行比较来确定差异表达基因 (DEG),参考人类癌症标.
主要成果:
- 发现几种基因在狗HCC中被差异地表达.
- 监管的DEG包括PARP3,DNMT1,FGF19,FGF23和RET. 这两种类型的DEG都受到监管.
- 下调的DEG包括KIT,FGFR2和FGF21.
结论:
- 这项研究提供了对犬类HCC.分子格局的关键见解.
- 识别特定的上调和下调基因提供了潜在的治疗点.
- 这些发现为更有效的向治疗犬肝癌铺平了道路.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


